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Systematic review meta-analysis
Factors associated with fatigue in hip and/or knee
osteoarthritis: a systematic review and best
evidence synthesis
Henrietta O. Fawole 1,2, Opeyemi A. Idowu2, Ukachukwu O. Abaraogu1,3,
Andrea Dell’Isola4, Jody L. Riskowski1, Kayode I. Oke2, Ade F. Adeniyi5,
Chidozie E. Mbada6, Martijn P. Steultjens1 and Sebastien F. M. Chastin1,7
Abstract
Objective The aim was systematically to identify and evaluate factors related to fatigue in individuals
with hip and/or knee OA.
Methods A systematic literature search was conducted using AMED, CINAHL, MEDLINE, ProQuest
and Web of Science Core Collections databases. Inclusion criteria comprised cross-sectional, case–
control or longitudinal studies on patients with a diagnosis of hip and/or knee OA that included self-
reported fatigue measures. Study quality was assessed using the National Heart, Lung and Blood
Institute quality appraisal tool, and factors were synthesized within a bio-behavioural framework. Study
designs and quality were combined to determine current evidence levels using best evidence synthesis
grading. The full review protocol is available from PROSPERO (PROSPERO 2019: CRD42019138571).
Results Twenty-four studies were included, of which 19 were high, 4 moderate and 1 low quality. There was
strong evidence of an association between poor self-reported physical function and high depressive symptoms
with higher fatigue. Moderate evidence of an association was found between severe pain, high numbers of
co-morbidities and low physical activity levels with higher fatigue. There was moderate or limited evidence
of no association between most sociodemographic factors and radiographic OA severity with fatigue.
Conclusion Targets for fatigue management might include improving physical function, reducing
depressive symptoms, pain and co-morbidities, and increasing physical activity levels. There is a need
for more rigorous longitudinal studies to understand the causal effect of fatigue determinants within the
hip and knee OA populations.
Key words: osteoarthritis, fatigue, factors, correlates, predictors, systematic review
Key messages
. Physical function, depression, co-morbidities, pain and physical inactivity are associated with fatigue based
on strong to moderate best evidence.
. Sociodemographics, body mass index and radiographic OA severity are not associated with fatigue based
on limited to moderate best evidence.
. To manage fatigue, physical function, depressive symptoms, pain, co-morbidities and physical activity could
be targeted.
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Introduction
OA is the most common form of arthritis and accounts
for >80% of global arthritis burden [1]. The recent surge
in the obesity epidemic and the increase in the global
ageing population have contributed to the higher global
prevalence of OA [1]. Hip and knee OA is expected to
become the ninth leading cause of years lived with dis-
ability by 2030 [2] and, consequently, continue to be a
major cause of reduced quality of life for those afflicted
[3]. Pain is the cardinal symptom of OA and a significant
contributor to functional limitations and reduction in
physical activity among individuals with OA [4]. Fatigue,
however, has recently emerged as an important and
prevalent symptom impacting the lives of individuals
with OA [5, 6].
Fatigue is generally defined as an unpleasant and
subjective feeling of tiredness, exhaustion or lack of en-
ergy [7]. Moreover, aside from pain, fatigue is a common
symptom and a significant concern for people with OA
[8–10]. Fatigue in OA has been identified as a research
priority [11] and recommended in rheumatic diseases,
including OA, to be considered as a top priority in clini-
cal practice [12]. Between 47 and 90% of those with OA
report some levels of fatigue [5, 13, 14], with >40%
reporting clinically significant fatigue levels [5, 13]. These
levels are higher than those reported for the general
population, where fatigue prevalence ranged between
13 and 25% [15–17]. Equally, fatigue levels were found
to be higher for those with OA relative to their age- and
sex-matched counterparts [18, 19].
With increasing interest in fatigue, the evidence on
OA-related symptoms, behaviours and socioeconomic
factors that contribute to fatigue preponderance has not
been established within the hip and/or knee OA popula-
tion, the largest population of those with OA. Evaluating
the evidence on correlates or predictors for fatigue in
hip and/or knee OA can help in identifying treatment
plans or interventions for management or reduction of
fatigue within these populations, thereby maximizing
overall patient outcomes and quality of life. In order to
increase the knowledge on fatigue aetiology in individuals
with hip or knee OA and to design appropriate targeted
fatigue interventions, the use of a conceptual framework
might be beneficial in the identification of potential multi-
factorial correlates of fatigue. Therefore, the overaching
aim of this systematic review was to identify and give an
overview of predictors or correlates of fatigue in hip
and/or knee OA populations using the bio-behavioural
conceptual framework [20, 21]. The bio-behavioural
conceptual framework was used in this systematic review
because it is likely that the aetiology of fatigue is through
biological or behavioural contributions [22]. Moreover,
the aim of the bio-behavioural model of symptom man-
agement is within the context of a health experience that
is based on interactions between biological, behavioural
and social factors and their effects to explain symptoms
or symptom clusters that subsequently affect health out-
comes, such as fatigue [22, 23].
Methods
Review
This review was conducted following the preferred
reporting items for systematic reviews and meta-
analyses (PRISMA) guideline [24]; see Supplementary
Data S1, available at Rheumatology Advances in
Practice online. A review protocol was registered with
the PROSPERO database in July 2019 (number
CRD42019138571).
Search strategy and article selection
Electronic databases were searched from inception to
18 March 2020: AMED and CINAHL (via EBSCOhost);
MEDLINE, ProQuest (Health and Medical Collections,
Nursing and Allied Health database, PsycINFO) and
Web of Science core collection. The search strategy
was formulated in Medline and was reviewed using the
PRESS guideline assessment form [25] by a researcher
experienced in systematic review methodology. Search
strings were translated and adapted for each database
search engine. The following keywords, medical head-
ings in combinations with specific database search
syntax, filters, limiters and Boolean operators were
used: ‘fatigue’ OR ‘vitality’ OR ‘tiredness’ AND ‘factors’
OR ‘correlates’ OR ‘predictors’ OR ‘determinants’ OR
‘risk factors’ OR ‘depression’ OR ‘sleep’ OR ‘pain’ AND
‘osteoarthritis’ OR ‘knee osteoarthritis’ OR ‘hip osteoar-
thritis’. The complete strategy implemented is presented
in Supplementary Table S1, available at Rheumatology
Advances in Practice online. Reference lists of selected
studies were searched to identify relevant studies, and
citations (using Google Scholar) of all eligible articles
and narrative reviews references were checked for fur-
ther eligible texts.
Study selection criteria
Inclusion and exclusion criteria
Peer-reviewed studies that included a hip and/or knee
OA population or sub-sample of hip and/or knee OA
diagnosed using radiographic evidence and/or clinical
diagnosis (as defined by the American College of
Rheumatology criteria) [26] or according to Kellgren–
Lawrence (KL) grading [27] or doctor/physician-
confirmed diagnosis and that measured fatigue as an
outcome or as a predictor or used subscale question-
naires for fatigue measurement (e.g. SF-36 vitality scale)
were eligible for inclusion. The following study designs
were included: observational studies (cohort, case–con-
trol and cross-sectional). Articles that included partici-
pants with hip and/or knee joint replacement, review
articles or grey literature or abstracts or non-human and
non-English studies were excluded.
Study selection
Studies identified by the search were screened indepen-
dently based on titles and abstracts by two authors
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(H.O.F. and O.A.I.). The eligible full texts were screened
further by H.O.F. and O.A.I. In cases of disagreement,
both authors discussed and reached a consensus.
Where consensus could not be reached, a third author
(U.O.A.) was consulted for the final decision.
Data extraction
Two authors (H.O.F. and O.A.I.) extracted the following
information independently from all included studies us-
ing a pre-piloted data extraction form: study setting,
study population, study design, sample size, fatigue
measurement tool, follow-up time, statistical analysis
method, both significant and non-significant factors as-
sociated with fatigue and strength of association.
Quality assessment
The National Heart, Lung, and Blood Institute (NHLBI)
quality appraisal tool, a widely used assessment tool
recommended by Cochrane for evaluating qualities of
observational and cross-sectional studies, was used to
evaluate internal validity and risk of bias [28, 29]. The
NHLBI comprises 14 items, of which 10 are applicable
to cross-sectional studies, and all 14 items are applica-
ble to observational cohort studies. Each item was
scored independently by two authors (H.O.F. and
O.A.I.). The NHLBI tool allowed for assessment of meth-
odological flaws, such as sampling, adjustment for con-
founders, study power and other relevant factors for
each study. The overall assessment of studies was rated
as high, moderate or low based on the risk of bias. In
order to capture limitations within the current evidence,
no studies were excluded based on the quality
assessment.
Data synthesis
There was no meta-analysis performed owing to the
high heterogeneity levels with regard to study popula-
tion, identified factors and fatigue outcome measure-
ments. Two authors (H.O.F. and O.A.I.) independently
grouped and classified the identified factors into individ-
ual, disease-specific, psychosocial, behavioural and bio-
logical groups (Supplementary Table S2, available at
Rheumatology Advances in Practice online) using the
bio-behavioural conceptual framework of fatigue in OA
[20, 21]. The synthesis decisions were reviewed until
both authors reached consensus.
The findings were presented using a narrative synthe-
sis to report factors that were or were not associated
with fatigue, and we performed a best evidence synthe-
sis of factors that were investigated in two or more stud-
ies and ranked evidence grading based on previous
studies [30–32] to grade the level of evidence supporting
the associations (Supplementary Table S3, available at
Rheumatology Advances in Practice online). Equally, we
classified studies according to study design, with the
preferred design being cohort study followed by case–
control design and, lastly, cross-sectional design. We
then ranked the studies according to their
methodological quality score. Also, identified factors
were classified with the direction and strength of associ-
ation using correlation or standardized coefficient as
weak (<0.3), moderate (0.3 to <0.7) and strong asso-
ciations (0.7) [33] or with odds ratios [34] where these
were reported. We adjudged results as consistent if the
factor was significantly associated with fatigue in the
same direction of the association. In studies where only
unstandardized coefficients were presented, we calcu-
lated the standardized beta (b) coefficient using this for-
mula: b ¼ [(standard deviation of independent variable)/
(standard deviation of dependent variable)]  unstandar-
dized (B) coefficient.
Results
Database searches identified a total of 1106 articles,
which were exported to Refworks, where duplicates
were removed. Removal of duplicates, screening for title
and abstracts yielded a total of 68 articles for full
screening. Twenty-four articles met the inclusion criteria
and were included in the review (Fig. 1).
The 24 studies included a total of 9475 patients with
knee and/or hip OA (Supplementary Table S4, available
at Rheumatology Advances in Practice online). Diagnosis
of OA in most of the included studies (n¼ 20; 83%) was
according to ACR criteria or KL grading [6, 9, 10, 13,
18, 19, 35–48]. The remaining four studies confirmed OA
based on a physician or rheumatologist diagnosis [49–
52]. Included study designs were cross-sectional
(n¼13, 54.2%), cohort (n¼ 9, 37.5%) or case–control
(n¼2, 8.3%). However, because the two case–control
studies presented either a 5-day repeated longitudinal
[18] or cross-sectional design [19] for data on the asso-
ciation between factors identified and fatigue, we used
the cohort or cross-sectional quality appraisal for these
two studies [18, 19]. Sample size varied considerably
across studies, ranging from 68 [35] to 3815 participants
[49]. Within the 24 eligible studies, there were 16 fatigue
measurement tools used. The visual analog scale (VAS)
was the most common outcome measure used (seven
studies, 29.2%) to assess fatigue in the studies in-
cluded; however, VAS anchors varied. Measurement
tools for identified factors based on bio-behavioural
groupings are presented in Supplementary Table S5,
available at Rheumatology Advances in Practice online.
Statistical analyses methods used in included studies
comprised multiple linear regression models (i.e. back-
wards eliminations, hierarchical), logistic regression,
Pearson’s correlation, Spearman partial correlation, mul-
tilevel modelling, longitudinal mixed modelling and path
analysis (Supplementary Table S4, available at
Rheumatology Advances in Practice online).
Quality assessment
Nineteen studies (nine cross-sectional [6, 9, 10, 19, 37,
44, 46, 49, 51] and 10 longitudinal [13, 18, 38–42, 48,
50, 52]) were rated as having high quality. Four studies
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(three cross-sectional [35, 36, 47] and one longitudinal
[45]) were of moderate quality, and one had low quality
(cross-sectional [43]). The potential risks of bias in most
studies were lack of sample size determination or power
calculation (n¼ 21) and blinding of outcome assessors
(n¼24) [Table 1]. The four studies rated as moderate
quality lacked clear specification and definition of study
populations and inadequate report of the rate of eligible
participants [35, 36, 45, 47] or lacked control for con-
founders [45]. The study rated low quality [43] lacked
clarity on the study population, inadequate report of the
rate of eligible participants, and lack of adjustment for
confounders.
Association between identified factors and fatigue
Factors associated with fatigue, with the direction and
strength of association and levels of best evidence, are
summarized in Figs 2–4 and Table 2, respectively.
Identified factors based on the bio-behavioural frame-
work are depicted in Supplementary Fig. S1, available at
Rheumatology Advances in Practice online.
Individual factors
Ten studies investigated the association between indi-
vidual factors (i.e. age, sex, education, BMI, race, living
situation, living circumstances, monthly bill payment, fi-
nancial status, co-morbidities, illness burden, activity-
limiting co-morbidities, diabetes, hypertension, back
pain, depression, sarcopenia, health status and vitality)
and fatigue in five cross-sectional [10, 19, 37, 46, 49]
and five longitudinal cohort studies [38, 40, 41, 48, 50].
Two individual factors (age and BMI) had moderate evi-
dence of no association with fatigue. Moderate evidence
was found for the association between high co-
morbidities/illness burden and higher fatigue. There was
limited evidence of no association between race (being
Black or non-Hispanic White) and level of education and
fatigue, and there was conflicting evidence for the asso-
ciation between sex (being female) and fatigue. The
remaining identified individual factors had insufficient ev-
idence on their association with fatigue because results
were reported from single studies (Supplementary Table
S6, available at Rheumatology Advances in Practice
online).
Disease-specific factors
Sixteen studies (8 cross-sectional [6, 19, 35, 37, 43, 44,
49, 51] and 8 longitudinal [13, 38, 40–42, 45, 48, 50]) ex-
amined the relationship between disease-specifc factors
(i.e. pain, momentary pain, hip pain, pain impact, OA
symptoms and disability, pain-adjusted physical activity,
joint stiffness, disability, knee strength, radiographic OA
severity, baseline fatigue and quality of life) and fatigue.
There was moderate evidence to support the associa-
tion between high pain and higher fatigue. Limited evi-
dence was found for the association between high
momentary pain, high baseline fatigue and high disability
with higher fatigue, and there was limited evidence of no
association between radiographic OA severity and fa-
tigue. Conflicting evidence was noted for the association
between joint stiffness and fatigue. There was insuffi-
cient evidence for the association between fatigue and
the remaining disease-specific factors (Supplementary
Table S6, available at Rheumatology Advances in
Practice online).
Psychosocial factors
A total of 11 studies assessed the association between
psychosocial factors (i.e. depressive symptoms, anxiety,
emotional well-being, pain catastrophizing, coping
behaviours and social support) and fatigue, of which five
were cross-sectional [9, 19, 37, 44, 49] and six were
longitudinal [38, 40–42, 48, 50]. Strong evidence was
FIG. 1 Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flow diagram
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found for the association between high depressive
symptoms and higher fatigue. Limited evidence was
noted for the association between high pain catastroph-
izing and higher fatigue. There was conflicting evidence
on the association between anxiety and social support
with fatigue. Emotonal well-being and coping behaviours
had insufficient evidence on their association with fa-
tigue based on findings from single studies.
Behavioural factors
Fifteen studies investigated the association between
behavioural factors (i.e. self-reported physical function,
performance-based physical function, aerobic function,
physical activity, momentary pacing behaviour and
sleep) and fatigue in seven cross-sectional [6, 19, 36,
37, 43, 44, 47] and eight longitudinal studies [13, 18,
38–41, 48, 52]. Strong evidence was found for the asso-
ciation between low self-reported physical function and
higher levels of fatigue. There was moderate evidence
that low physical activity is asociated with higher fatigue.
There was conflicting evidence on the association be-
tween performance-based physical function and sleep
with fatigue. There was insufficient evidence for the
association between aerobic function and momentary
pacing behaviour with fatigue levels because this was
reported in only one study for each of these factors.
TABLE 1 National Heart, Lung and Blood Institute (NHLBI) quality assessment for observational cohort and cross-sec-
tional studies (24 studies)
Authors Q1 Q2 Q3 *Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Overall
grade
Wolfe (1999) [6] Y Y Y Y/Y N N N Y Y N/A Y NR N/A Y High
Creamer et al. (1999) [35] Y N NR Y/Y N N N Y Y N/A Y NR N/A Y Moderate
Creamer et al. (2000) [36] Y N NR Y/Y N N N Y Y N/A Y NR N/A Y Moderate
Wolfe et al. (2004) [49] Y Y Y Y/Y N N N Y Y N Y NR N/A Y High
Sale et al. (2008) [9] Y Y Y Y/Y Y N N Y Y N/A Y NR N/A Y High
Murphy et al. (2008) [18] Y Y Y Y/Y N Y Y Y Y Y Y NR Y Y High
Murphy et al. (2010) [19] Y Y Y Y/Y N N N Y Y N Y NR N/A N High
Stebbings et al. (2010) [37] Y Y Y Y/Y Y N N Y Y N/A Y NR N/A Y High
Snijders et al. (2011) [13] Y Y Y Y/Y N N Y Y Y Y Y N Y Y High
Hawker et al. (2011) [38] Y Y Y Y/Y N N Y Y Y Y Y NR Y Y High
van Dijk et al. (2011) [39] Y Y Y Y/Y N N Y Y Y Y Y N Y Y High
Murphy et al. (2013) [40] Y Y Y Y/Y N N Y Y Y Y Y N Y Y High
Murphy & Kratz (2014) [41] Y Y Y Y/Y N N Y Y Y Y Y NR Y Y High
Zullig et al. (2015) [10] Y Y Y Y/Y N N N Y Y N/A Y NR N/A Y High
Smith & Parmelee
(2016) [50]
Y Y Y N/Y N Y Y Y Y Y Y CD Y Y High
Carlesso et al. (2016) [42] Y Y Y Y/Y N Y Y Y Y N Y NR Y Y High
Huang et al. (2017) [43] Y Y NR Y/Y N N N Y Y N/A Y NR N/A N Low
Allen et al. (2019) [51] Y Y Y Y/Y N N N Y Y N/A Y NR N/A Y High
Aree-Ue et al. (2019) [44] Y Y Y Y/Y Y N N Y Y N/A Y NR N/A N High
Smith et al. 2019 [52] Y Y Y N/Y N Y Y Y Y Y Y NR Y Y High
Fu et al. (2019) [45] Y NR NR Y/Y N N Y Y Y Y Y NR N Y Moderate
Vlietstra et al. (2019) [46] Y Y Y Y/Y N N N Y Y N/A Y NR N/A Y High
Martinez et al. (2019) [47] Y N NR Y/Y N N N Y Y N/A Y NR N/A Y Moderate
Fawole et al. (2020) [48] Y Y Y Y/Y N Y Y Y Y N Y NR Y Y High
*Same population/uniform eligibility. CD: cannot determine; N: no; N/A: not applicable; NR: not reported; Y: yes. Q1: was
the research question or objective clearly stated? Q2: was study population clearly specified and defined? Q3: was the
participation rate of eligible persons 50%? Q4: were all the subjects selected or recruited from the same or similar popu-
lations (including the same time period)? Were inclusion and exclusion criteria for being in the study pre-specified and ap-
plied uniformly to all participants? Q5: was a sample size justification, power description, or variance and effect estimates
provided? Q6: for the analysis, were the exposure(s) of interest measured prior to the outcome(s) being measured? Q7:
was the time frame sufficient that one could reasonably expect to see an association between exposure and outcome if it
existed? Q8: for exposures that vary in amount or level, did the study examine different levels of the exposure as related
to the outcome (e.g. categories of exposure, or exposure measured as continuous variable)? Q9: were the exposure meas-
ures (independent variables) clearly defined, valid, reliable and implemented consistently across all study participants?
Q10: was the exposure(s) assessed more than once over time? Q11: were the outcome measures (dependent variables)
clearly defined, valid, reliable and implemented consistently across all study participants? Q12: were the outcome asses-
sors blinded to the exposure status of participants? Q13: was loss to follow-up after baseline 20%? Q14: were key po-
tential confounding variables measured and adjusted statistically for their impact on the relationship between exposure(s)
and outcome(s)?
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Biological factor
Of the 24 studies, only a cross-sectional study included
a biological factor, CRP, a measure of systemic inflam-
mation [37], rendering the evidence on the association
between systematic inflammation (CRP) and fatigue to
be insufficient (Supplementary Table S6, available at
Rheumatology Advances in Practice online).
Discussion
The aim of this systematic review was to summarize
current epidemiological evidence of potential factors as-
sociated (correlates and predictors) with fatigue in peo-
ple with hip and/or knee OA using the bio-behavioural
conceptual framework. Owing to high levels of
FIG. 2 Strength of association between individual and biological factors identified and fatigue
Associations are presented as correlation (r) or standardized (b) coefficients or odd ratios (OR).
FIG. 3 Strength of association between disease-specific factors and fatigue
Associations are presented as correlation (r) or standardized (b) coefficients or odd ratios (OR).
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heterogeneity in study designs, fatigue measurement
tools and factors identified, the review used a narrative
and best evidence synthesis, which enabled the grading
of factors into different levels of evidence. There were
24 studies that evaluated factors associated with fatigue
in people with hip and/or knee OA, with the majority
having cross-sectional designs.
The best evidence synthesis found strong evidence for
the association between poor self-reported physical func-
tion and high depressive symptoms with higher fatigue
levels. Moderate evidence was found for the association
between a high number of co-morbidities or illness bur-
den, high pain and low physical activity with higher fa-
tigue. Moderate or limited evidence was noted for no
association between sociodemographic factors (age, edu-
cation, race, living situation or circumstances), BMI and
radiographic OA severity with fatigue. Conflicting evidence
was found for the association between poor performance-
based physical function, high anxiety, high joint stiffness,
poor sleep and low social support with higher fatigue.
Limited or insufficient evidence was available for a major-
ity of the disease-specific factors identified, suggesting
that it is unclear whether fatigue pathways for those with
hip and/or knee OA differ from fatigue pathways in other
pathological states. Our discussion will focus on factors
identified as having strong, moderate or inconclusive evi-
dence and notable exceptions.
The findings of this review underscore the importance
of modifiable factors, including perceived physical func-
tion, depressive symptoms, pain and physical activity,
as potential targets for consideration in fatigue manage-
ment in patients with hip and/or knee OA, because the
relationships between these factors and fatigue were
supported by strong or moderate levels of evidence.
Generally, people with hip and knee OA have a high
prevalence of low physical function [53], high depressive
symptoms [54], severe pain [55] and low physical activ-
ity [56]. When present, these modifiable factors are
reported to worsen health outcomes and quality of life in
this population [57–61]. Thus, their inclusion as potential
treatment targets might be important in the design of
treatment plans and for optimal fatigue management. A
previous review on fatigue interventions identified non-
pharmacological interventions, such as exercise and
FIG. 4 Strength of association between psychosocial and behavioural factors and fatigue
Associations are presented as correlation (r) or standardized (b) coefficients or odd ratios (OR).
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TABLE 2 Overview and best evidence synthesis regarding associations with a high level of fatigue in hip and/or knee OA
At least two studies Association found No association found Best evidence
Individual factors
Older age One HQ cohort study and one
HQ cross-sectional study [37,
38]
One HQ cross-sectional study
reported an association but
did not indicate the direction
of association, and this has
not been included in the evi-
dence synthesis [10]*
Four HQ cohort studies, two
HQ cross-sectional studies
[37, 40, 41, 48–50]
Moderate evidence of no
association
Sex (being female) Female
One HQ cohort study [38]
Female
Two HQ cohort studies [41,
48]
One HQ cohort study did not
report which of the gender
type (male or female) had
no association with fatigue
[50]*
Conflicting evidence
High BMI One HQ cross-sectional study
[19]
Four HQ cohort studies
[40, 41, 48, 50]
Moderate evidence of no
association
One HQ cross-sectional study
reported no direction of asso-
ciation, and this has not been
included in the evidence
synthesis [10]*
Education levels – Two HQ cohort studies
[38, 50]
Limited evidence of no
association
Race (being Black or
non-Hispanic White)
– Two HQ cohort studies
[48, 50]




– Two HQ cohort studies
[38, 48]




Four HQ cohort studies [38, 40,
41, 48] and one HQ cross-
sectional study [10]
One HQ cohort studies [41] Moderate evidence of
association
Disease-specific factors
High pain Three HQ cohort studies and
seven HQ, one MQ and one LQ
cross-sectional studies [6, 19,
35, 37, 38, 41, 43, 44, 49–51]
Two HQ cohort studies and
one HQ, one MQ, and one
LQ cross-sectional studies
[13, 35, 37, 43, 48]
Moderate evidence of
association
High momentary pain One HQ cohort study and two
HQ cross-sectional studies
[19, 40, 50]
– Limited evidence of
association





High disability Two HQ cross-sectional studies
[37, 49]





– One HQ cohort study and two
HQ cross-sectional studies
[19, 37, 48]
Limited evidence of no
association
High baseline fatigue One HQ cohort study and one
HQ cross-sectional study
[41, 48]





Six HQ cohort studies and four
HQ cross-sectional studies [9,
10, 37, 38, 40–42, 48–50]





High anxiety One HQ cohort study and one




High pain catastrophizing Two HQ cohort studies [38, 42] One HQ cohort study [48] Limited evidence of
association
Low social support One HQ cohort study [38] One HQ cohort study [42] Conflicting evidence
(continued)
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cognitive behavioural therapies, as the common and likely
interventions for reduction of fatigue [62]. Both interven-
tions are also used to decrease the negative impact of
high levels of depressive symptoms, severe pain and poor
physical function [63, 64] and, as such, might influence
fatigue reduction in hip and knee OA. However, owing
to limited longitudinal studies in the present review, future
studies are warranted to ascertain the predictive nature of
these modifiable factors on fatigue.
In general, co-morbidities or illness burden was posi-
tively associated with increased fatigue, suggesting that
the presence of co-morbidities or illness burden might
worsen fatigue. Furthermore, epidemiological evidence
indicates that co-morbidities escalate the impact of
OA and, accordingly, worsen OA symptoms in the long
term [65].
Surprisingly, the radiographic severity of hip or knee
OA was not significantly associated with fatigue. This
lack of significant association implies that the amount of
articular damage around the knee or hip joint seems to
be unrelated to fatigue. Likewise, this lack of association
between radiographic evidence and fatigue has been
reported for the RA population [37]. The premise that
radiographic evidence of OA does not always equate to
symptoms in OA [66, 67] might be a plausible reason for
our finding. Furthermore, there are strong speculations
that OA is a multifactorial entity with multiple pheno-
types [68, 69], and it is possible that structural pheno-
types do not play a role in fatigue symptomology in OA.
This finding might be of clinical importance for research-
ers planning future studies of fatigue and lower limb OA,
because this result of no association also suggests
that objective measures of hip or knee OA severity or
KL score might not be a determinant or prognosticator
for fatigue, which has the potential to reduce study
costs. However, the current evidence level is limited
owing to the availability of two cross-sectional studies
and one longitudinal study.
It is important to note that although there was moder-
ate evidence of no association between age, BMI and
fatigue, these findings might have been impacted by the
variation in fatigue assessment tools in the studies in-
cluded; nonetheless, our findings are similar to those of
prior research in rheumatological conditions [70, 71].
Moreover, four of the six studies included in the best ev-
idence synthesis for BMI and fatigue were longitudinal
studies, but only one had a long follow-up time (2 years)
[48], with others averaging 5–7 days. It is unlikely that
the effect of BMI on fatigue could be detected within
such a short temporal scale.
The association of self-reported physical function,
depressive symptoms and pain with fatigue is in accor-
dance with previous research [70, 72]. The strong and
moderate evidence found for these factors highlights the
fact that fatigue is associated with clinical and generic
factors that are modifiable and, as such, might have
implications for clinical management of fatigue in this
population. In contrast, inconclusive evidence was noted
for the relationship between performance-based physi-
cal function and fatigue relative to the strong evidence
found for subjective physical function. One explanation
could be attributable to the high numbers of studies
that investigated the relationship between subjective
physical function and fatigue. Another explanation could
be related to the different measures used to evaluate
performance-based function (i.e. timed up and go, 6 min
walk, and 10 and 20 m timed walk) and the dependence
on only two traditional longitudinal studies. The mis-
match between objective performance-based findings
and subjective measures warrants the need for both
physical function measures to be included in fatigue
studies until studies elucidate causes and ways to ad-
just for differences in perception and performance of
physical function in the hip and knee OA population.
Likewise, mixed evidence was noted for sleep, female
sex and joint stiffness with fatigue. The inconclusive
finding for sleep and fatigue is similar to findings for
the RA population [70], suggesting that the relationship
between sleep and fatigue is not well understood.
However, this mixed evidence on the relationship
TABLE 2 Continued




Four HQ cohort studies and six
HQ cross-sectional studies,
one MQ and one LQ cross-
sectional study [6, 13, 19, 36–
40, 43, 49]







Three HQ cohort studies and one
HQ cross-sectional study [39,
40, 44, 48]




Low physical activity Three HQ cohort studies
[18, 40, 52]
One HQ cohort study [41] Moderate evidence of
association
Poor sleep One HQ cross-sectional study
and one MQ cross-sectional
study [37, 47]
Two HQ cohort studies
[40, 48]
Conflicting evidence
*Note that other factors identified from only one study and/or where directions of association have not been stated have
not been included in this evidence synthesis. HQ: high quality; LQ: Low quality; MQ: moderate quality.
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between sleep with fatigue could be attributable to
different sleep constructs measured in the included
studies (sleep quality [47, 48] or sleep disturbance [37]
or sleep efficiency [40]). Also, variation in fatigue tools
could have led to the conflicting evidence, because
studies that used more comprehensive fatigue tools
(e.g. SF-12 vitality scale or multidimensional assessment
of fatigue–global fatigue index) found a significant
association relative to those that used a single numerical
rating scale or VAS. On the contrary, our conflicting find-
ings between the relationship of female sex and fatigue
conflict with that of a previous review [70]. These results
between female sex and fatigue might differ because of
the different pathways of RA and OA. RA includes both
a genetic and an environmental pathway [73], whereas
OA also includes other pathways of aetiology, such as
traumatic injury or repetitive joint over-use [74].
Moreover, the majority of the studies that reported no
association between fatigue and sex used numerical rat-
ing scales to measure fatigue. In the future, studies that
evaluate fatigue should include information on the type
of OA (primary or secondary) and assess fatigue with
more comprehensive fatigue instruments. Most of the in-
conclusive evidence regarding joint stiffness and fatigue
might be attributable to the use of different fatigue
instruments (15 cm VAS and multidimensional assess-
ment of fatigue–global fatigue index) and studies not
including objective measures for joint stiffness, such as
joint range of movement or tendon elasticity. Moreover,
emerging evidence suggests that altered tendon elastic-
ity owing to structural deformity from pathology might
increase the energy requirement during movement and,
consequently, lead to fatigue [75, 76]. Although no con-
clusions have been drawn because work is ongoing,
there are debates regarding available quantities of
elastin in tendons and its potential role in initiation of fa-
tigue. In OA, the research on systemic inflammation and
fatigue is nascent [21], but this emerging evidence cre-
ates a basis for further investigation of the relationship
between fatigue and OA. However, studies on other
chronic diseases (e.g. chronic fatigue syndrome and
type 2 diabetes) have evaluated the relationship be-
tween systemic inflammation and fatigue, with evidence
suggesting that systemic inflammatory makers are posi-
tively associated with increased fatigue both cross-
sectionally and over time [77, 78]. Thus, it could be hy-
pothesized that systemic inflammation might lead to al-
teration of molecules that might adversely influence cell
functions, thereby distorting cellular energy production
and, consequently, leading to subjective feelings of
fatigue [79].
Strengths and limitations
Although our review is comprehensive and systematic
and the first systematic review to be conducted on fac-
tors associated with fatigue in people with knee and/or
hip OA, it has some limitations. Our search might have
missed some studies that were published in non-English
language journals; thus, other factors might not have
been identified. Owing to the high levels of heterogeneity
with regard to study populations, identified factors and
fatigue outcome measurement tools, a meaningful quan-
titative synthesis (meta-analysis) of effect estimates was
not possible. Consequently, the adoption of the best evi-
dence synthesis approach was the most appropriate in
this review.
The fatigue measurement tools used in the included
studies generally have positive and good psychometric
properties [37, 80–82]; nonetheless, many of these fa-
tigue tools have not been validated for the hip and knee
OA population. Thus, the use of fatigue instruments
designed for other rheumatic and chronic conditions (i.e.
RA, multiple sclerosis, cancer) might lead to important
issues, such as contamination bias [83]. Thus, there is a
need for well-designed and validated fatigue instruments
for hip and knee OA populations. Furthermore, the use
of diverse fatigue measurement tools and different tools
for factors identified might have influenced the associa-
tions found, consequently impacting our findings and
limiting generalizations. Thus, we suggest that more
studies should use uniform measures of fatigue.
Although the NHBLI quality appraisal tool is valid for
assessing internal validity and risk of bias in observa-
tional and cross-sectional studies [28, 29], there were
other potential risks of bias that were not considered in
the NHBLI. These include pre-definition of key con-
founders and consideration of adjustment for a priori
key confounders and attrition bias (handling of missing
data). Furthermore, although another study [20] has
evaluated fatigue more broadly, there is a need to ex-
amine fatigue specifically in those with hip and knee OA
and provide a starting point reference on the best evi-
dence available in specific OA-related fatigue literature.
Strengths of this review included the robust classifica-
tion of factors using the bio-behavioural conceptual
framework of fatigue in OA and the best evidence syn-
thesis as a means for amalgamating results. Given that
meta-analysis was not possible, the best evidence syn-
thesis and evidence grading of all the data from the sys-
tematic review is likely to help streamline future studies
of fatigue through identification of factors that need to
be researched further in order to deepen our under-
standing of fatigue within the hip and knee OA popula-
tion. Although, the approach used for best evidence
synthesis is a common one [30–32], this approach does
not consider the methodological quality limitation
within each study (i.e. whether the weaknesses
identified lead to bias), thus results should be inter-
preted with caution. Furthermore, the use of a more
recent Grading of Recommendation, Assessment,
Development and Evaluation (GRADE) approach might
have led to a more robust rating of certainty of evi-
dence [84]; it was not feasible to apply this approach
because fatigue was considered in this review as either
an outcome or a predictor. This meant that studies dif-
fered in the predictors assessed, outcomes assessed
and analytical approaches, resulting in heterogeneity in
prediction models.








ap/article/5/1/rkab013/6154305 by guest on 06 M
ay 2021
Recommendation for future studies and practice
Current evidence strongly suggests that to manage fa-
tigue in hip and knee OA, modifiable factors, such as
physical function, depressive symptoms, pain and
physical activity, need to be targeted. However, owing
to the potential for circularity vs causality of fatigue,
depression, pain and physical function, there is a need
to investigate the potential longitudinal links between
fatigue and these factors to enhance our understand-
ing of fatigue aetiology in hip and knee OA. In con-
trast, older age, BMI and disease (OA) severity should
not be targets for fatigue intervention. More studies
that comprise rigorous longitudinal designs, a long-
term follow-up period and consistent fatigue measures
with adjustment for key confounders are warranted.
This could lead to identification of predictors of fatigue
and enhancement of current evidence. Also, given that
the measurement of fatigue is incomplete without con-
sideration for its multidimensionality, classifying fatigue
in relationship to a specific activity with fixed intensity
and duration provides a more objective approach to
fatigue assessment [19, 85], a concept known as fati-
gability. Future studies should consider both assess-
ment of fatigability and dimensions of fatigue in those
with hip and knee OA. Equally, comprehensive investi-
gations of disease-specific factors and other factors
identified using the bio-behavioural conceptual frame-
work are needed to provide more robust and compre-
hensive evidence on fatigue predictors over time.
Conclusions
There is strong or moderate evidence that high numbers
of co-morbidities or illness burden and modifiable factors,
such as high depressive symptoms, low levels of self-
reported physical function, high pain and low physical ac-
tivity levels, are associated with greater fatigue, making
these factors possible targets for fatigue reduction in hip
and/or knee OA populations. More rigorous longitudinal
studies are needed in order to substantiate the current ev-
idence and to investigate the causal effect and direction-
ality of other potential identified determinants of fatigue in
order to understand the aetiology and mechanisms of fa-
tigue within the knee and/or hip OA populations.
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